Alessandro Brunelli
亚历山德罗·布鲁内利
MD
Consultant Thoracic Surgeon顾问胸外科医生
👥Biography 个人简介
Alessandro Brunelli is a leading European thoracic surgeon renowned for developing preoperative risk assessment models for lung resection. His EuroSCORE-adapted models and ESTS guidelines for functional evaluation have become international standards for surgical risk stratification.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Surgical Risk Models
Developed and validated predictive models for cardiopulmonary morbidity and mortality after lung resection, enabling objective patient selection and surgical planning for high-risk cases.
ESTS Guidelines
Chaired European Society of Thoracic Surgeons expert panels producing evidence-based guidelines on preoperative functional evaluation, adopted across Europe and referenced globally.
Representative Works 代表性著作
European risk models for morbidity (EuroLung1) and mortality (EuroLung2) to predict outcome following thoracic surgery
European Journal of Cardio-Thoracic Surgery (2017)
Derived and validated EuroLung risk models from large ESTS database, providing the most comprehensive European surgical risk tool for thoracic procedures.
Physiologic evaluation of the patient with lung cancer being considered for resectional surgery
Chest (2013)
Comprehensive ACCP evidence-based guideline on preoperative assessment, shaping clinical decision-making for lung cancer surgery worldwide.
🏆Awards & Recognition 奖项与荣誉
📄Data Sources 数据来源
Last updated: 2026-01-15 | All information from publicly available academic sources
Related Experts 相关专家
Lecia V. Sequist
Massachusetts General Hospital / Harvard Medical School
Mark G. Kris
Memorial Sloan Kettering Cancer Center
Geoffrey R. Oxnard
Foundation Medicine / Harvard Medical School
Alice T. Shaw
Novartis Institutes for BioMedical Research / Massachusetts General Hospital
关注 亚历山德罗·布鲁内利 的研究动态
Follow Alessandro Brunelli's research updates
留下邮箱，当我们发布与 Alessandro Brunelli（Leeds Teaching Hospitals NHS Trust）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment